Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance - Johnson & Johnson (NYSE:JNJ)

Credit Suisse analyst Trung Huynh increased the price for Johnson & Johnson (NYSE: JNJ) to $175 from $170, 

Related Keywords

Joanne Wuensch ,Johnson ,Hernandez Valadez ,Trung Huynh ,Credit Suisse ,Med Devices ,